The effects of recombinant human insulin-like growth factor-1/insulin-like growth factor binding protein-3 administration on lipid and carbohydrate metabolism in recreational athletes.
Nishan GuhaSimon P NevittMichael FrancisWalailuck BöhningDankmar BöhningPeter H SönksenRichard I G HoltPublished in: Clinical endocrinology (2020)
rhIGF-1/rhIGFBP-3 administration for 28 days reduced insulin concentration, improved insulin sensitivity and had significant effects on lipid profile including decreased fasting triglycerides.